WebCimalgex 8 mg cimikoksib 8 mg Cimalgex 30 mg cimikoksib 30 mg Cimalgex 80 mg cimikoksib 80 mg Potpuni popis pomoćnih tvari vidi u odjeljku 6.1. 3. FARMACEUTSKI OBLIK Tablete za žvakanje. Cimalgex 8 mg, tablete: duguljaste, bijele do svijetlosmeđe, tablete za žvakanje s jednim urezom s obje strane. WebCimalgex chewable tablets are suitable for the treatment of pain and inflammation associated with osteoarthritis, and the control of peri-operative pain due to soft tissue, or orthopedic surgery in dogs. The active substance in Cimalgex is cimicoxib. The tablets should be administered orally. Cimalgex tablets can be administered with or without …
Cimalgex European Medicines Agency
WebCimalgex kauwtabletten zijn geschikt voor de behandeling van pijn en ontsteking geassocieerd met osteoartritis en de bestrijding van perioperatieve pijn ten gevolge van … WebCimicoxib (UR-8880 trade name Cimalgex) is a nonsteroidal anti-inflammatory drug (NSAID) used in veterinary medicine to treat dogs for pain and inflammation associated with osteoarthritis and for the management of pain and inflammation associated with surgery. It acts as a COX-2 inhibitor. portfolio heloc lenders
I PIELIKUMS VETERINĀRO ZĀĻU APRAKSTS - European …
WebCimalgex 8 mg tsimikoksiib 8 mg Cimalgex 30 mg tsimikoksiib 30 mg Cimalgex 80 mg tsimikoksiib 80 mg Abiainete terviklik loetelu on esitatud punktis 6.1. 3. RAVIMVORM Närimistabletid. Cimalgex 8 mg tabletid: piklikud, valged või helepruunid närimistabletid, mille mõlemal küljel on poolitusjoon. Tabletid saab jagada võrdseteks poolteks. Web20mg Librela is an innovative drug for the alleviation of pain associated with osteoarthritis in dogs. Osteoarthritis in dogs is a common disease and has been associated with pain. Librela 20mg is a caninised monoclonal antibody. Each vial of 1ml Librela contains 20mg bedinvetmab and enhances the natural process of clearing away immune complexes, … WebCimalgex . Cimicoxibum. Tento dokument je souhrnem Evropské veřejné zprávy o hodnocení (European Public Assessment Report, EPAR). Objasňuje, jakým způsobem vyhodnotil Výbor pro veterinární léčivé přípravky (CVMP) předloženou dokumentaci, aby mohl vypracovat doporučení ohledně používání přípravku. portfolio hemg 650